CareCloud to Present at the LD Micro Invitational XV

Rhea-AI Summary

CareCloud (Nasdaq: CCLD) has announced its participation in the 15th Annual LD Micro Invitational at the Westin Grand Central Hotel in New York on April 9-10, 2025. The healthcare technology solutions provider will deliver its corporate presentation on April 10, 2025 at 3:30 p.m. ET.

During the event, management will showcase the company's:

• Recent developments and innovative solutions
• Strategic growth initiatives
• Two recent acquisitions
• Conversion of Series A preferred stock
• Significant profitability growth throughout 2024

The team will also engage in one-on-one meetings with institutional and individual investors to discuss growth opportunities and value creation strategies.

SOMERSET, N.J., April 07, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the “Company”) (Nasdaq: CCLD, CCLDO), a leading provider of practice management, healthcare technology and AI-driven solutions to medical practices across the country, is pleased to announce its participation in the 15th Annual LD Micro Invitational at the Westin Grand Central Hotel in New York on April 9-10, 2025. The Company is scheduled to present on April 10, 2025 at 3:30 p.m. ET.

CareCloud’s management team will deliver a corporate presentation highlighting the Company’s recent developments, innovative solutions, and strategic growth initiatives. Additionally, the team will participate in one-on-one meetings with institutional and individual investors to explore opportunities and discuss CareCloud’s roadmap for continued growth and value creation.

“We are excited to highlight CareCloud's recent milestones, including two recent acquisitions, the conversion of our Series A preferred stock, and our significant profitability growth throughout 2024,” said Stephen Snyder, Co-CEO of CareCloud.

About LD Micro 

LD Micro, a wholly owned subsidiary of Freedom US Markets, was founded in 2006 with the sole purpose of being an independent resource in the micro-cap space. Through the LD Micro Index and annual investor conferences, LD has served as an invaluable asset to all those interested in discovering the next generation of great companies. For more information on LD Micro, visit www.ldmicro.com.

About CareCloud 

CareCloud brings disciplined innovation and generative AI to the business of healthcare. Our suite of technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud to help them improve patient care while reducing administrative burdens and operating costs. Learn more about our products and services including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM) and digital health at www.carecloud.com. 

Follow CareCloud on LinkedIn, X and Facebook.

Disclaimer 

This press release is for information purposes only, and does not constitute an offer to sell or solicitation of an offer to buy, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state or jurisdiction. 

Forward-Looking Statements 

This press release contains various forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may,” “might,” “will,” “shall,” “should,” “could”, “intends,” “expects,” “plans,” “goals,” “projects,” “anticipates,” “believes,” “seeks,” “estimates,” “predicts,” “possible,” “potential,” “target,” or “continue” or the negative of these terms or other comparable terminology. 

Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct.

Forward-looking statements in this press release include, without limitation, statements reflecting management's expectations for future financial performance and operating expenditures, expected growth, profitability and business outlook, the impact of pandemics on our financial performance and business activities, and the expected results from the integration of our acquisitions. 

These forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our (or our industry’s) actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all of the risks and uncertainties that could have an impact on the forward-looking statements, including without limitation, risks and uncertainties relating to the Company’s ability to manage growth, migrate newly acquired customers and retain new and existing customers, maintain cost-effective global operations, increase operational efficiency and reduce operating costs, predict and properly adjust to changes in reimbursement and other industry regulations and trends, retain the services of key personnel, develop new technologies, upgrade and adapt legacy and acquired technologies to work with evolving industry standards, compete with other companies’ products and services competitive with ours, and other important risks and uncertainties referenced and discussed under the heading titled “Risk Factors” in the Company’s filings with the Securities and Exchange Commission. 

The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not assume any obligations to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made. 

SOURCE CareCloud 

Company Contact: 
Norman Roth 
Interim Chief Financial Officer and Corporate Controller 
CareCloud, Inc.
nroth@carecloud.com 

Investor Contact:
Stephen Snyder 
Co-Chief Executive Officer 
CareCloud, Inc. 
ir@carecloud.com

FAQ

When is CareCloud (CCLD) presenting at the LD Micro Invitational XV?

CareCloud will present on April 10, 2025 at 3:30 p.m. ET at the Westin Grand Central Hotel in New York.

What key achievements will CareCloud (CCLD) discuss at the LD Micro Invitational 2025?

CareCloud will discuss two recent acquisitions, Series A preferred stock conversion, and significant profitability growth throughout 2024.

What type of meetings will CareCloud (CCLD) conduct at the LD Micro conference?

CareCloud will conduct one-on-one meetings with institutional and individual investors to discuss growth opportunities and value creation.

Where is the 2025 LD Micro Invitational XV being held for CCLD's presentation?

The event is being held at the Westin Grand Central Hotel in New York on April 9-10, 2025.